Literature DB >> 11350506

Failure to detect an association with IL1 genotypes in European Caucasians with generalised early onset periodontitis.

P J Hodge1, M P Riggio, D F Kinane.   

Abstract

OBJECTIVES: In order to elucidate the genetic background to EOP it is useful to investigate associations with genetic polymorphisms of immune response genes, whose products play a r le in the inflammatory process. The aim of this study was to examine IL1A and IL1B genetic polymorphisms in unrelated European white Caucasian patients with generalised early-onset periodontitis (GEOP).
MATERIAL AND METHODS: Polymerase chain reaction (PCR) amplification of the ILIA (-889) gene and IL1B (+3953) gene (56 patients, 56 controls) was carried out and PCR products subjected to restriction fragment length polymorphism (RFLP) analysis.
RESULTS: There were no significant differences between patients and controls for any of the genotype or allele frequencies investigated (p = 1.0). Smoking status was also included as a covariate but this did not alter the results. Furthermore, expression of the composite genotype described by Kornman and coworkers was also investigated in these subjects. No significant differences were found between patients and controls whether smoking was included as a covariate or not.
CONCLUSION: The lack of any association between the IL1 polymorphisms and GEOP, in the population presented here, brings into doubt the usefulness of these candidate genes as markers of susceptibility to this form of periodontitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350506     DOI: 10.1034/j.1600-051x.2001.028005430.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction.

Authors:  H Marotte; P Farge; P Gaudin; C Alexandre; B Mougin; P Miossec
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

2.  Interleukin-1β rs1143634 polymorphism and aggressive periodontitis susceptibility: a meta-analysis.

Authors:  Yong-Ji Chen; Ying Han; Min Mao; Ya-Qin Tan; Wei-Dong Leng; Xian-Tao Zeng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.

Authors:  Barbara Gawrońska-Szklarz; Andrzej Siuda; Mateusz Kurzawski; Dariusz Bielicki; Wojciech Marlicz; Marek Droździk
Journal:  Eur J Clin Pharmacol       Date:  2010-04-08       Impact factor: 2.953

4.  Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS.

Authors:  Konstantinos Aggelakis; Fani Zacharaki; Efthimios Dardiotis; Georgia Xiromerisiou; Vana Tsimourtou; Styliani Ralli; Maria Gkaraveli; Dimitris Bourpoulas; Paraskevi Rodopoulou; Alexandros Papadimitriou; Georgios Hadjigeorgiou
Journal:  Neurol Sci       Date:  2009-10-30       Impact factor: 3.307

Review 5.  Interleukin polymorphisms in aggressive periodontitis: A literature review.

Authors:  Pooja Maney; Jessica Leigh Owens
Journal:  J Indian Soc Periodontol       Date:  2015 Mar-Apr

6.  Evaluation of interleukin -1B (+3954) gene polymorphism in patients with chronic and aggressive periodontitis: A genetic association study.

Authors:  Sujata S Masamatti; Ashish Kumar; Tarun Kumar A Baron; Dhoom S Mehta; Kishore Bhat
Journal:  Contemp Clin Dent       Date:  2012-04

7.  Interleukin-1α -899 (+4845) C→T polymorphism is not associated with aggressive periodontitis susceptibility: A meta-analysis based on 19 case-control studies.

Authors:  Wan-Fen Wang; Jun Shi; Shao-Juan Chen; Yu-Ming Niu; Xian-Tao Zeng
Journal:  Biomed Rep       Date:  2014-02-19

Review 8.  Interleukin-1 Genotype in Periodontitis.

Authors:  Aniela Brodzikowska; Renata Górska; Jan Kowalski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2019-07-19       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.